Novo Nordisk's booming obesity drugs & diabetes portfolio make it a top growth play. Click here to read an analysis of NVO ...

Novo Nordisk now has an Ozempic pill. Citing a Novo spokesperson, pharmaceuticals news site BioPharmaDive reported yesterday ...

From here, FWD P/E has much more room to go up than before. Also, in comparison to LLY, Novo Nordisk trades at only half of their Forward P/E. Of course, LLY has greater growth estimates ...

You can reach Elaine on Signal at elaineywchen.70. Novo Nordisk has signed another obesity pact, this one for an oral drug that works via an uncommon mechanism and could potentially help patients ...

In the latest trading session, Novo Nordisk (NVO) closed at $78.79 ... It's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong ...

Shares of Novo Nordisk have surged more than 185% in the past five years. During the same time frame, total revenues have jumped 129% on a reported basis, while the net profit margin consistently ...

Brazil is among the five largest markets for Novo Nordisk, the Danish drugmaker said. It also exports to more than 70 countries out of Brazil. With the investment, the production capacity will ...